FDA News Briefs for July 28, 2020

These Food and Drug Administration (FDA) developments came in this week:FDA Reissues EUA for COVID-19 Diagnostic TestThe FDA has reissued the emergency use authorization (EUA) for the LabCorp COVID-19 RT-PCR Test to include two new indications for use: testing for...

FDA Approves Tecartus for MCL

On July 24, 2020, the Food and Drug Administration (FDA) approved a biologics license application (BLA) for Tecartus (brexucabtagene autoleucel, Kite Pharma Inc.) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL).Tecartus, a...